Interferon monotherapy for dialysis patients with chronic hepatitis C: An analysis of the literature on efficacy and safety
Hepatitis C, Chronic
Kidney Failure, Chronic
Our analysis suggests that interferon monotherapy is more effective in patients on dialysis than in patients with normal renal function. Interferon monotherapy is associated with more adverse events in dialysis patients. The optimal dose and duration of interferon monotherapy and selection criteria of dialysis patients need to be studied further in clinical trials.